Phenotypic screening platform identifies statins as enhancers of immune cell-induced cancer cell death
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Phenotypic screening platform identifies statins as enhancers of immune cell-induced cancer cell death ; volume:23 ; number:1 ; day:17 ; month:2 ; year:2023 ; pages:1-10 ; date:12.2023
BMC cancer ; 23, Heft 1 (17.2.2023), 1-10, 12.2023
- Urheber
-
Selvin, Tove
Berglund, Malin
Lenhammar, Lena
Jarvius, Malin
Nygren, Peter
Fryknäs, Mårten
Larsson, Rolf
Andersson, Claes R.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-023-10645-4
- URN
-
urn:nbn:de:101:1-2023042421143704875683
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Selvin, Tove
- Berglund, Malin
- Lenhammar, Lena
- Jarvius, Malin
- Nygren, Peter
- Fryknäs, Mårten
- Larsson, Rolf
- Andersson, Claes R.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Live cell screening identifies glycosides as enhancers of cardiomyocyte cell cycle activity
Systems biology drug screening identifies statins as enhancers of current therapies in chronic lymphocytic leukemia
Chromatin accessibility differences between alpha, beta, and delta cells identifies common and cell type-specific enhancers
High throughput compound screening in neuronal cells identifies statins as activators of ataxin 3 expression
Zebrafish chemical screen identifies HDAC inhibitors as pharmacological enhancers of hematopoietic stem and progenitor cells
STARR-seq identifies active, chromatin-masked, and dormant enhancers in pluripotent mouse embryonic stem cells
Statins impact on epigenetics of tumor cells
Cell-type-directed design of synthetic enhancers
Transcriptionally active enhancers in human cancer cells
Phenotypic Screen Identifies a Small Molecule Modulating ERK2 and Promoting Stem Cell Proliferation
Juxtaglomerular Cell Phenotypic Plasticity
Binding of HMGN proteins to cell specific enhancers stabilizes cell identity
Live cell screening identifies glycosides as enhancers of cardiomyocyte cell cycle activity
Systems biology drug screening identifies statins as enhancers of current therapies in chronic lymphocytic leukemia
Chromatin accessibility differences between alpha, beta, and delta cells identifies common and cell type-specific enhancers
High throughput compound screening in neuronal cells identifies statins as activators of ataxin 3 expression
Zebrafish chemical screen identifies HDAC inhibitors as pharmacological enhancers of hematopoietic stem and progenitor cells
STARR-seq identifies active, chromatin-masked, and dormant enhancers in pluripotent mouse embryonic stem cells
Statins impact on epigenetics of tumor cells
Cell-type-directed design of synthetic enhancers
Transcriptionally active enhancers in human cancer cells
Phenotypic Screen Identifies a Small Molecule Modulating ERK2 and Promoting Stem Cell Proliferation
Juxtaglomerular Cell Phenotypic Plasticity
Binding of HMGN proteins to cell specific enhancers stabilizes cell identity
Live cell screening identifies glycosides as enhancers of cardiomyocyte cell cycle activity
Systems biology drug screening identifies statins as enhancers of current therapies in chronic lymphocytic leukemia
Chromatin accessibility differences between alpha, beta, and delta cells identifies common and cell type-specific enhancers
High throughput compound screening in neuronal cells identifies statins as activators of ataxin 3 expression
Zebrafish chemical screen identifies HDAC inhibitors as pharmacological enhancers of hematopoietic stem and progenitor cells
STARR-seq identifies active, chromatin-masked, and dormant enhancers in pluripotent mouse embryonic stem cells
Statins impact on epigenetics of tumor cells
Cell-type-directed design of synthetic enhancers
Transcriptionally active enhancers in human cancer cells
Phenotypic Screen Identifies a Small Molecule Modulating ERK2 and Promoting Stem Cell Proliferation
Juxtaglomerular Cell Phenotypic Plasticity